Europe Balloon Catheter Market

Europe Balloon Catheter Market Size (2023 to 2028):

The size of the Europe Balloon Catheter Market is expected to reach USD 1.91 billion by 2028 from USD 1.17 billion in 2023 and is predicted to hike at a prominent CAGR of 10.35% during the forecast period. The Europe Balloon Catheter market is developing at a rapid pace.

High growth in the drug-coated and specialty segments, rise in elder people population, and lifestyle changes among the people boost the balloon catheter market growth during the analysis period in Europe. Escalating death rates in some countries of Europe because of increased cardiac disorders lead to the rising utilization of balloon catheters for the therapies of narrow arteries. Steady growth in different chronic heart diseases, more than 200 million people are suffering from Peripheral Artery Disease (PAD), according to an article published by the NCB in 2018. Nearly 12.3% of the population aged 60 years and above is predicted to increase to 22% by 2020 during the region's forecast period. Also, favorable FDA policies propel market growth.

Lack of health care services in the region is limiting the market growth over the period. The high cost of the stent treatment and coronary angioplasty, the threat of infection and artery breakdown involved with balloon catheterization, and substitutes such as bypass surgery hinder the balloon catheter market growth of this region.

This research report on the Europe Balloon Catheter Market has been segmented and sub-segmented into the following categories:

By Product Type:

• Cutting Balloon Catheter
• Scoring Balloon Catheter
• Normal Balloon Catheter
• Drug Eluting Balloon Catheter
• Stent Graft Balloon Catheter

By Raw Material:

• Polyurethane
• Nylon

By Disease Indication:

• Coronary Artery Disease
• Peripheral Vascular Disease

By End User:

• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories
• Public Hospitals
• Private Hospitals

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regional Analysis:

The European region is assumed as a developed market and is anticipated to witness significant growth in the forecast period.

The balloon catheter in Europe is pretended as a developed market and is predicted to witness significant growth in the market. Growing rates of strokes, heart attacks, and other heart-related diseases are accelerating the market growth over the period.

Germany is the primary leading country in the balloon catheter in the region during the analysis period. Increasing investments towards research and development in healthcare and mounting demand for new, non-invasive devices like catheters fuel the growth of the balloon catheter market of the region.

Germany follows France in leading the market in balloon catheters of the region. A growing number of product launches for balloon catheters and the assumption of inorganic strategies by many key players. An increasing number of coronary artery bypass surgeries increase because of the rising aging population with diabetic cases and high blood cholesterol levels in them. United Kingdom is expected to have considerable growth in the balloon catheter market during the period due to increasing significance for minimally invasive surgical procedures like Minimally Invasive Cardiothoracic Surgery (MICS) is predicted to contribute to the market growth.

Prominent Companies leading the Europe Balloon Catheter Market Profiled in the Report are B. Braun Melsungen AG, Abbott Vascular, Terumo Medical, Corp., Medtronic, Biosensors International, Ltd., Boston Scientific, Goodman, and Cordis.MicroPort Scientific, Corp., Simeks Medical, and AngioScore, Inc.